Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept
Sign Up to like & getrecommendations! Published in 2021 at "Transplantation"
DOI: 10.1097/tp.0000000000003824
Abstract: Background. Belatacept may impair humoral immunity, impacting the effectiveness of SARS-CoV-2 mRNA vaccines in transplant recipients. We investigated immunogenicity after SARS-CoV-2 mRNA vaccines in kidney transplant recipients who are and are not taking belatacept. Methods.… read more here.
Keywords: cov mrna; kidney transplant; transplant recipients; taking belatacept ... See more keywords